Prosecution Insights
Prosecution Insights
10 pending office actions • 6 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (10%) |
| §102 only | 1 (10%) |
| §112 only | 2 (20%) |
| Double-patenting only | 2 (20%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOTTINGHAM, KYLE GREGORY | 2 | 59.3% | +34.9% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +20.3% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.8% |
| MOORE, SUSANNA | 1 | 67.9% | +31.6% |
| MCDOWELL, BRIAN E | 1 | 74.2% | +30.4% |
| KUCKLA, ANNA GRACE | 1 | 52.4% | +55.0% |
| MAHLUM, JONATHAN DAVIS | 1 | 51.5% | +20.8% |
| CHICKS, ASHLI ARIANA | 1 | 63.2% | +45.9% |
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 62.9% | +60.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18033748 | OLIGONUCLEOTIDES USEFUL FOR MODULATION OF SPLICING | CHONG, KIMBERLY | 5d overdue |
| 17802702 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | MAHLUM, JONATHAN DAVIS | — |
| 17802833 | FUSED BICYCLIC COMPOUNDS USEFUL FOR MODULATING NUCLEIC ACID SPLICING | CHICKS, ASHLI ARIANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18014059 | 2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TRE | MCDOWELL, BRIAN E | 87d overdue |
| 18033748 | OLIGONUCLEOTIDES USEFUL FOR MODULATION OF SPLICING | CHONG, KIMBERLY | 5d overdue |
| 17917842 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | KUCKLA, ANNA GRACE | 6d |
| 17802863 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | NOTTINGHAM, KYLE GREGORY | 30d |
| 18014057 | 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES | MOORE, SUSANNA | 78d |
| 18713561 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | WHITE, DAWANNA SHAR-DAY | — |
| 17917868 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | NOTTINGHAM, KYLE GREGORY | — |
| 17802702 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | MAHLUM, JONATHAN DAVIS | — |
| Art Unit | Apps |
|---|---|
| 1624 | 2 |
| 1621 | 2 |
| 1626 | 2 |
| 1636 | 1 |
| 1625 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18713561 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | WHITE, DAWANNA SHAR-DAY | — | DP | Non-Final OA | — | Pending | May 24, 2024 |
| 18033748 | OLIGONUCLEOTIDES USEFUL FOR MODULATION OF SPLICING | CHONG, KIMBERLY | 1636 | §102§103§112 | Non-Final OA | 5d overdue | Pending | Apr 25, 2023 |
| 18014057 | 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES | MOORE, SUSANNA | 1624 | §112DPOther | Final Rejection | 78d | Pending | Dec 30, 2022 |
| 18014059 | 2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TRE | MCDOWELL, BRIAN E | 1624 | §112 | Final Rejection | 87d overdue | Pending | Dec 30, 2022 |
| 17917868 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | NOTTINGHAM, KYLE GREGORY | 1621 | DP | Non-Final OA | — | Pending | Oct 07, 2022 |
| 17917842 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | KUCKLA, ANNA GRACE | 1626 | §102Other | Non-Final OA | 6d | Pending | Oct 07, 2022 |
| 17802863 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | NOTTINGHAM, KYLE GREGORY | 1621 | §112Other | Final Rejection | 30d | Pending | Aug 26, 2022 |
| 17802702 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | MAHLUM, JONATHAN DAVIS | 1625 | §102§112Other | Final Rejection | — | Pending | Aug 26, 2022 |
| 17802833 | FUSED BICYCLIC COMPOUNDS USEFUL FOR MODULATING NUCLEIC ACID SPLICING | CHICKS, ASHLI ARIANA | 1626 | §102§103 | Non-Final OA | — | Pending | Aug 26, 2022 |
| 17802747 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103Other | Final Rejection | — | Pending | Aug 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial